These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9521231)

  • 1. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention.
    Grover SA; Paquet S; Levinton C; Coupal L; Zowall H
    Arch Intern Med; 1998 Mar; 158(6):655-62. PubMed ID: 9521231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?
    Grover S; Coupal L; Lowensteyn I
    Can J Cardiol; 2008 Dec; 24(12):891-8. PubMed ID: 19052668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events.
    Grover SA; Coupal L; Paquet S; Zowall H
    Arch Intern Med; 1999 Mar; 159(6):593-600. PubMed ID: 10090116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?
    Grover SA; Coupal L; Lowensteyn I
    Can J Cardiol; 2008 Apr; 24(4):261-6. PubMed ID: 18401465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?
    Grover SA; Coupal L; Zowall H; Alexander CM; Weiss TW; Gomes DR
    Diabetes Care; 2001 Jan; 24(1):45-50. PubMed ID: 11194239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease.
    Lowensteyn I; Coupal L; Zowall H; Grover SA
    J Cardiopulm Rehabil; 2000; 20(3):147-55. PubMed ID: 10860196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study.
    Ferket BS; van Kempen BJ; Heeringa J; Spronk S; Fleischmann KE; Nijhuis RL; Hofman A; Steyerberg EW; Hunink MG
    PLoS Med; 2012; 9(12):e1001361. PubMed ID: 23300388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity.
    Grover SA; Abrahamowicz M; Joseph L; Brewer C; Coupal L; Suissa S
    JAMA; 1992 Feb; 267(6):816-22. PubMed ID: 1732653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?
    Grover SA; Coupal L; Zowall H; Dorais M
    Circulation; 2000 Aug; 102(7):722-7. PubMed ID: 10942738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal management of hyperlipidemia in primary prevention of cardiovascular disease.
    Raza JA; Babb JD; Movahed A
    Int J Cardiol; 2004 Dec; 97(3):355-66. PubMed ID: 15561319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice.
    Eaton CB; McQuade W; Glupczynski D
    Fam Med; 1994 Oct; 26(9):587-92. PubMed ID: 7843510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
    Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease.
    Kostis JB
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):297-309. PubMed ID: 17605096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    Hong KN; Fuster V; Rosenson RS; Rosendorff C; Bhatt DL
    J Am Coll Cardiol; 2017 Oct; 70(17):2171-2185. PubMed ID: 29050566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.